Could the Novel Oral Anticoagulants Be Used for Coronary Artery Aneurysm?

Table 1

The cases of treating CAAs with NOACs.

Author-first	Publication year	Location of CAAs	Type of anticoagulants	Antiplatelet agents	Follow-up time (month)
Grigorios et al. [15]	2017	RCA	Rivaroxaban	Aspirin^a, clopidogrel	>3
Choi et al. [16]	2018	RCA, LAD, LCX	Rivaroxaban	Clopidogrel	11
Yuksel et al. [17]	2015	Coronary thrombosis	Rivaroxaban	—	2
Waqas et al. [18]	2019	RCA, LAD, LCX	Warfarin followed by rivaroxaban	Ticagrelor, aspirin	—
Tomioka et al. [19]	2016	RCA	Warfarin followed by apixaban	Aspirin	12

^aStopped after one month.